Crossmark

CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial

Crossref DOI link: https://doi.org/10.1186/s12885-018-4997-y

Published Online: 2018-11-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hu, Huabin

Huang, Jin

Lan, Ping

Wang, Lei

Huang, Meijin

Wang, Jianping

Deng, Yanhong
License Information

Text and Data Mining valid from 2018-11-20
More Information

Article History

Received: 6 September 2018

Accepted: 25 October 2018

First Online: 20 November 2018

Ethics approval and consent to participate

: The institutional review board (IRB) of The Sixth Affiliated Hospital of Sun Yat-Sen University approved the present study (Approval number: 06-08-2010) and all documented consent from all patients who participated in the study.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.